[OPNT] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[OPNT] Opiant Pharmaceuticals, Inc.
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 190.90%
YoY- 212.96%
Quarter Report
OPNT's Result
OPNT's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 29/06/18 31/07/17 31/07/16 CAGR
Revenue 2,326 9,314 6,258 6,693 3,106 3,772 312 40.41%
PBT -11,704 1,684 -216 1,521 -1,397 212 -1,090 49.34%
Tax 32 518 4 -57 -80 550 -39 -
NP -11,737 1,684 -216 1,578 -1,397 -339 -1,090 49.42%
Tax Rate - -30.74% - 3.75% - -260.23% - -
Total Cost 14,063 7,631 6,474 5,115 4,503 4,111 1,403 47.62%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 29/06/18 31/07/17 31/07/16 CAGR
NP Margin -504.52 18.08 -3.46 23.58 -44.98 -8.99 -348.93 6.42%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 29/06/18 31/07/17 31/07/16 CAGR
EPS -2.31 0.39 -0.05 0.39 -0.52 0.00 0.00 -
EPS Diluted -2.31 0.31 -0.05 0.31 -0.52 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.